论文部分内容阅读
目的:评价乙型肝炎(以下简称乙肝)病毒携带者、急慢性乙肝、乙肝所致肝硬化和肝癌病人的年经济负担。方法:从山东省社区人群和住院治疗的乙肝病毒感染住院病人中选取调查对象问卷调查,获取年费用信息,查阅住院病人病历登录本次住院费用。结果:社区人群非活动性HBsAg携带者、慢性HBsAg携带者、慢性乙肝、乙肝肝硬化的年经济负担为0.81万元、0.90万元、1.20万元、1.15万元和0.96万元;住院病人原发性肝癌、重型乙肝、肝硬化失代偿期、代偿期、慢性乙肝以及急性乙肝的年经济负担分别为37.72万元、13.81万元、15.67万元、14.34万元、12.74万元和6.67万元。结论:乙肝带来沉重的经济负担,需加大住院病人的医疗保险报销比例,积极防控乙肝病毒感染具有巨大的社会效益和经济效益。
Objective: To evaluate the annual economic burden of hepatitis B (hereinafter referred to as hepatitis B) virus carriers, acute and chronic hepatitis B, hepatitis B cirrhosis and liver cancer patients. Methods: A questionnaire survey was conducted among inpatients with community-based hepatitis B virus infection and inpatient treatment of hepatitis B virus infection in Shandong Province to obtain the annual cost information, and to check the inpatient expenses for the inpatient records. Results: The annual economic burden of inactive HBsAg carriers, chronic HBsAg carriers, chronic hepatitis B and hepatitis B cirrhosis was 0.81 million, 0.90, 1.20, 1.15, and 0.96, respectively. Inpatients The annual economic burden of primary liver cancer, severe hepatitis B, decompensated liver cirrhosis, compensated hepatitis, chronic hepatitis B and acute hepatitis B were 377,200 yuan, 138,100 yuan, 156,700 yuan, 143,400 yuan, 127,400 yuan and 6.67 Million. Conclusion: Hepatitis B brings a heavy financial burden. Hepatitis insurance need to increase the proportion of medical insurance reimbursement for inpatients, and it has great social and economic benefits to prevent and control hepatitis B virus infection.